Cargando…

1617 Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study

Detalles Bibliográficos
Autores principales: Teppler, Hedy, Shuldyakov, Andrey, Gankina, Natalia, Kulagin, Valeriy, Nagimova, Firaya, Shimonova, Tatiana, Sonin, Dmitriy, Sotnikov, Vladimir, Zakharova, Natalia, Homony, Brenda, Wang, Deng, Moshkovich, Grigoriy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782091/
http://dx.doi.org/10.1093/ofid/ofu052.1163
_version_ 1783295112856469504
author Teppler, Hedy
Shuldyakov, Andrey
Gankina, Natalia
Kulagin, Valeriy
Nagimova, Firaya
Shimonova, Tatiana
Sonin, Dmitriy
Sotnikov, Vladimir
Zakharova, Natalia
Homony, Brenda
Wang, Deng
Moshkovich, Grigoriy
author_facet Teppler, Hedy
Shuldyakov, Andrey
Gankina, Natalia
Kulagin, Valeriy
Nagimova, Firaya
Shimonova, Tatiana
Sonin, Dmitriy
Sotnikov, Vladimir
Zakharova, Natalia
Homony, Brenda
Wang, Deng
Moshkovich, Grigoriy
author_sort Teppler, Hedy
collection PubMed
description
format Online
Article
Text
id pubmed-5782091
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57820912018-03-01 1617 Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study Teppler, Hedy Shuldyakov, Andrey Gankina, Natalia Kulagin, Valeriy Nagimova, Firaya Shimonova, Tatiana Sonin, Dmitriy Sotnikov, Vladimir Zakharova, Natalia Homony, Brenda Wang, Deng Moshkovich, Grigoriy Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5782091/ http://dx.doi.org/10.1093/ofid/ofu052.1163 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Teppler, Hedy
Shuldyakov, Andrey
Gankina, Natalia
Kulagin, Valeriy
Nagimova, Firaya
Shimonova, Tatiana
Sonin, Dmitriy
Sotnikov, Vladimir
Zakharova, Natalia
Homony, Brenda
Wang, Deng
Moshkovich, Grigoriy
1617 Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study
title 1617 Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study
title_full 1617 Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study
title_fullStr 1617 Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study
title_full_unstemmed 1617 Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study
title_short 1617 Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study
title_sort 1617 safety, tolerability, and antiretroviral activity of raltegravir in hiv-1 infected russian children and adolescents – a 24 week study
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782091/
http://dx.doi.org/10.1093/ofid/ofu052.1163
work_keys_str_mv AT tepplerhedy 1617safetytolerabilityandantiretroviralactivityofraltegravirinhiv1infectedrussianchildrenandadolescentsa24weekstudy
AT shuldyakovandrey 1617safetytolerabilityandantiretroviralactivityofraltegravirinhiv1infectedrussianchildrenandadolescentsa24weekstudy
AT gankinanatalia 1617safetytolerabilityandantiretroviralactivityofraltegravirinhiv1infectedrussianchildrenandadolescentsa24weekstudy
AT kulaginvaleriy 1617safetytolerabilityandantiretroviralactivityofraltegravirinhiv1infectedrussianchildrenandadolescentsa24weekstudy
AT nagimovafiraya 1617safetytolerabilityandantiretroviralactivityofraltegravirinhiv1infectedrussianchildrenandadolescentsa24weekstudy
AT shimonovatatiana 1617safetytolerabilityandantiretroviralactivityofraltegravirinhiv1infectedrussianchildrenandadolescentsa24weekstudy
AT sonindmitriy 1617safetytolerabilityandantiretroviralactivityofraltegravirinhiv1infectedrussianchildrenandadolescentsa24weekstudy
AT sotnikovvladimir 1617safetytolerabilityandantiretroviralactivityofraltegravirinhiv1infectedrussianchildrenandadolescentsa24weekstudy
AT zakharovanatalia 1617safetytolerabilityandantiretroviralactivityofraltegravirinhiv1infectedrussianchildrenandadolescentsa24weekstudy
AT homonybrenda 1617safetytolerabilityandantiretroviralactivityofraltegravirinhiv1infectedrussianchildrenandadolescentsa24weekstudy
AT wangdeng 1617safetytolerabilityandantiretroviralactivityofraltegravirinhiv1infectedrussianchildrenandadolescentsa24weekstudy
AT moshkovichgrigoriy 1617safetytolerabilityandantiretroviralactivityofraltegravirinhiv1infectedrussianchildrenandadolescentsa24weekstudy